Laser mammography moves toward PMA

Article

Imaging Diagnostic Systems' hopes of joining the mammography sweepstakes are pinned on its computed tomography laser mammography (CTLM) system gaining FDA premarket approval next year.IDS in Plantation, FL, has been developing its system for several

Imaging Diagnostic Systems' hopes of joining the mammography sweepstakes are pinned on its computed tomography laser mammography (CTLM) system gaining FDA premarket approval next year.

IDS in Plantation, FL, has been developing its system for several years. It hopes to complete the PMA process early in 2001. Another company, Advanced Research and Technology (ART) of Montreal, is working on a similar system, called SoftScan.

Both SoftScan and IDS's CTLM system train the laser energy on one side of the breast and place a detector on the other side to catch the photons after they pass through the tissue.

The ART system uses a stationary light source to create 2-D images, whereas CTLM's lasers rotate around the breast to create 3-D tomographic images. ART likewise hopes to clear the FDA in 2001 and begin marketing its product in 2002.

Both systems are considered adjuncts to x-ray mammography. n

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.